Betta Pharmaceuticals Hits Day Low of CNY 56.56 Amid Price Pressure

Betta Pharmaceuticals Co., Ltd. experienced significant market activity on October 15, 2025, with the stock declining by 11.32%. During the trading session, it reached an intraday low of CNY 56.56. This decline is notable when compared to the China Shanghai Composite, which only fell by 0.62% on the same day.
Over the past week, Betta Pharmaceuticals has seen a decrease of 13.35%, and its performance over the last month shows a drop of 18.15%. Despite these short-term challenges, the company has demonstrated a strong performance over the past year, with a return of 30.59%, significantly outperforming the China Shanghai Composite's 17.69% gain.

Financial metrics indicate that Betta Pharmaceuticals holds a market capitalization of CNY 27,699 million and a price-to-earnings ratio of 72.00. The company also boasts a return on equity of 6.92% and a dividend yield of 0.30%. However, its long-term performance remains mixed, with a notable decline of 50.39% over the past five and ten years.